Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Mar;104(6):1433-9.
doi: 10.1111/j.1471-4159.2007.05194.x. Epub 2007 Dec 18.

The GSK3 hypothesis of Alzheimer's disease

Claudie Hooper  1 , Richard Killick, Simon Lovestone
Affiliations
Free PMC article
Review

The GSK3 hypothesis of Alzheimer's disease

Claudie Hooper et al. J Neurochem. 2008 Mar.
Free PMC article

Abstract

Glycogen synthase kinase 3 (GSK3) is a constitutively active, proline-directed serine/threonine kinase that plays a part in a number of physiological processes ranging from glycogen metabolism to gene transcription. GSK3 also plays a pivotal and central role in the pathogenesis of both sporadic and familial forms of Alzheimer's disease (AD), an observation that has led us to coin the 'GSK3 hypothesis of AD'. According to this hypothesis, over-activity of GSK3 accounts for memory impairment, tau hyper-phosphorylation, increased beta-amyloid production and local plaque-associated microglial-mediated inflammatory responses; all of which are hallmark characteristics of AD. If our 'GSK3 hypothesis of AD' is substantiated and GSK3 is indeed a causal mediator of AD then inhibitors of GSK3 would provide a novel avenue for therapeutic intervention in this devastating disorder.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
GSK3 and its role in AD. Over-activity of GSK3 caused either by aberrant Wnt or insulin signaling in sporadic AD cases or through familial mutations in PS or APP in FAD, might play an integral role in disease progression. GSK3 mediates the hyper-phosphorylation of tau, the increased production of Aβ from APP (via β and γ secretase-mediated cleavage) and results in impairments in learning and memory and could potentially heighten microglial-mediated inflammatory responses in the local vicinity of Aβ plaques.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alvarez G, Munoz-Montano JR, Satrustegui J, Avila J, Bogonez E, az-Nido J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett. 1999;453:260–264. - PubMed
    1. Anderton BH, Betts J, Blackstock WP, et al. Sites of phosphorylation in tau and factors affecting their regulation. Biochem. Soc. Symp. 2001;67:73–80. - PubMed
    1. Asuni AA, Hooper C, Reynolds CH, Lovestone S, Anderton BH, Killick R. GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt. Eur. J. Neurosci. 2006;24:3387–3392. - PubMed
    1. Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, Gama-Sosa M, Neve R, Robakis NK. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 2004;23:2586–2596. - PMC - PubMed
    1. Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW, Lee CM. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci USA. 2000;97:11074–11079. - PMC - PubMed

MeSH terms

Substances